Skip to main content
Tumour Marker Explainer

High CA-125 on Your Blood Test

What a raised CA-125 tumour marker means, the most common benign explanations, and when it's time to see your GP or gynaecologist — explained calmly.
Analyse My Results Free

Free to use · No credit card · Works with any Australian lab

The Quick Answer

CA-125 (cancer antigen 125) is a protein measured in your blood, mainly used to monitor known ovarian cancer and to help assess a pelvic mass already seen on ultrasound. The usual Australian normal range is below 35 U/mL. It is not a general screening test for well women with no symptoms.

A raised CA-125 is common and very often benign, especially if you are premenopausal. The most frequent explanations — in rough order — are endometriosis, uterine fibroids, having your period, pregnancy, ovarian cysts, and pelvic inflammatory disease. A single mildly raised value usually settles when the test is repeated at a different point in your cycle.

Normal: below 35 U/mL
Mildly raised: 35-100 U/mL
Moderately raised: 100-200 U/mL
Markedly raised: above 200 U/mL

What Is CA-125 and Why Was It Ordered?

CA-125 is short for cancer antigen 125, a large protein (also known as MUC16) found on the surface of cells lining the fallopian tubes, the uterus, and the abdominal cavity (peritoneum). When these tissues are irritated, inflamed, stretched, or damaged, small amounts of the protein leak into the bloodstream, which is what your blood test detects.

In Australia, CA-125 is used in two main situations. First, to monitor women already diagnosed with epithelial ovarian cancer — tracking whether treatment is working and watching for recurrence over time. Second, alongside pelvic ultrasound, to help assess the likelihood that a newly discovered pelvic or ovarian mass is benign or requires specialist review. It is not recommended as a screening test for women without symptoms or a known mass, because large studies have shown it does not reduce deaths from ovarian cancer when used this way, and produces too many false alarms.

Because so many common, everyday gynaecological and abdominal conditions also irritate the same tissue lining, a raised CA-125 by itself — especially in a premenopausal woman with no pelvic mass on ultrasound — is far more likely to reflect one of those benign causes than cancer. Context always matters: your age, menopausal status, symptoms, and ultrasound findings are interpreted together, never the CA-125 number alone.

Benign Causes of a Raised CA-125

Causes are grouped as gynaecological (related to the uterus, ovaries and pelvis) or other benign causes that irritate the same peritoneal lining from elsewhere in the abdomen. Both groups can raise CA-125 well above the normal cutoff without any cancer being present.

Endometriosis
Gynaecological
35-100 U/mL
Very common

One of the most common causes of a mildly raised CA-125 in premenopausal women. Severe endometriosis with ovarian endometriomas (chocolate cysts) can push levels higher.

Uterine fibroids
Gynaecological
35-100 U/mL
Very common

Benign muscle growths in the uterus wall. Larger or multiple fibroids are more likely to be associated with a mild CA-125 rise.

Menstruation (your period)
Gynaecological
35-75 U/mL
Very common

Normal shedding of the uterine lining and mild pelvic irritation around ovulation and menstruation transiently raises CA-125. Repeating the test later in the cycle often shows it back within range.

Pregnancy
Gynaecological
35-100 U/mL
Common

CA-125 is often raised in the first trimester and again briefly after birth as the uterus and pelvic tissues undergo rapid change. Not a cause for concern in an otherwise normal pregnancy.

Benign ovarian cysts
Gynaecological
35-200 U/mL
Common

Simple functional cysts and benign complex cysts can raise CA-125, particularly if they are large or have bled internally. Ultrasound appearance matters far more than the number itself.

Pelvic inflammatory disease (PID)
Gynaecological
35-150 U/mL
Less common

Infection and inflammation of the uterus, tubes and ovaries irritates the pelvic lining. CA-125 typically falls once the infection is treated with antibiotics.

Ascites and liver disease
Other benign
Often very high (200+ U/mL)
Common in this context

Cirrhosis and other causes of abdominal fluid (ascites) are well known to produce markedly raised CA-125 through irritation of the peritoneum, sometimes mimicking advanced ovarian cancer on the number alone.

Recent abdominal or pelvic surgery
Other benign
35-150 U/mL
Common

Any recent operation inside the abdomen or pelvis - including a caesarean or laparoscopy - irritates the peritoneal lining and can raise CA-125 for several weeks while healing settles.

Peritonitis or diverticulitis
Other benign
35-200 U/mL
Less common

Inflammation of the abdominal lining from any cause, including a diverticulitis flare, can raise CA-125 in a similar way to gynaecological causes.

Heart failure
Other benign
35-100 U/mL
Less common

Fluid build-up around the lungs and abdomen in heart failure can mildly elevate CA-125, likely through the same serosal irritation mechanism as ascites.

When It Matters More: What to Mention to Your GP

A raised CA-125 carries more weight when it is combined with certain symptoms, a pelvic mass, or your menopausal status and family history. None of these on their own confirm cancer, but they are the details your GP will specifically ask about.

Persistent bloating
Worth mentioning

Bloating that is new, does not come and go with your usual cycle, and occurs most days for several weeks is worth mentioning, especially alongside a raised CA-125.

Pelvic or abdominal pain
Worth mentioning

Ongoing pain or pressure in the lower abdomen or pelvis that is not explained by your period or a known condition such as endometriosis.

Feeling full quickly or difficulty eating
Worth mentioning

Early satiety - feeling full after only a small meal - can reflect pressure from a pelvic mass on nearby bowel and stomach.

Needing to urinate urgently or more often
Worth mentioning

A pelvic mass pressing on the bladder can cause new urinary frequency or urgency that persists for weeks.

Unexplained weight loss
Discuss promptly

Losing weight without trying, particularly combined with reduced appetite, should always be discussed with your GP promptly.

Postmenopausal bleeding
Discuss promptly

Any vaginal bleeding after menopause is abnormal and needs assessment regardless of your CA-125 result.

Family history of ovarian, breast or bowel cancer
Worth mentioning

A strong family history, particularly with a known BRCA1, BRCA2 or Lynch syndrome gene fault, changes how a raised CA-125 is interpreted and may prompt genetic counselling.

Being postmenopausal with a new pelvic finding
Worth mentioning

CA-125 is a more useful risk indicator after menopause, because most of the common premenopausal benign causes (period, ovulation, fibroids shrinking) become less likely.

Red Flags — When to See Your GP Promptly

Most raised CA-125 results, particularly in premenopausal women, can be safely followed up at a routine GP appointment. But certain combinations of findings should prompt a phone call to your GP within days rather than weeks:

Postmenopausal woman with a pelvic mass and rising CA-125

This combination is the strongest indication for prompt gynaecological (or gynaecological oncology) referral. Risk-scoring tools such as RMI or ROMA are used to guide urgency.

Bloating, pelvic pain or early fullness most days for more than three weeks

Based on the Ovarian Cancer Symptom Index, symptoms that are new, persistent and frequent (rather than occasional) are the pattern doctors look for, more than any single blood result.

CA-125 that keeps rising on repeat testing

A single mildly raised value that settles on a repeat test is reassuring. A value that continues climbing over weeks to months is not explained by a period or ovulation and needs review.

New abdominal swelling or fluid (ascites) with a pelvic mass

Ascites alongside a pelvic or ovarian mass raises the level of concern and usually prompts same-week specialist assessment.

Strong family history of ovarian, breast or bowel cancer

A known or suspected BRCA1, BRCA2 or Lynch syndrome gene fault in the family changes risk assessment and may warrant earlier referral and genetic counselling.

Rapid abdominal distension over a period of weeks

A noticeably and rapidly growing abdomen, distinct from normal bloating, warrants a same-week GP appointment and likely urgent ultrasound.

What Your GP Does Next — The Workup

Australian GPs generally follow a fairly standard pathway after a raised CA-125. Knowing the sequence helps explain why the next test is being ordered, and why nothing further may be needed at all.

1
Confirm the timing of the test

Because CA-125 can rise around ovulation and during a period, your GP will often simply repeat the test at a different point in your menstrual cycle before doing anything else, particularly if you are premenopausal and have no symptoms.

2
Arrange a pelvic ultrasound

A transvaginal and/or transabdominal ultrasound is the key first-line investigation. It looks for an ovarian mass, cyst characteristics (simple versus complex), fibroids, endometriomas, or ascites, and is far more informative than the CA-125 number on its own.

3
Calculate a risk score if a mass is found

If ultrasound shows a pelvic or ovarian mass, your doctor may calculate a Risk of Malignancy Index (RMI) using your CA-125, menopausal status and ultrasound features, or a ROMA score using CA-125 plus a second marker, HE4.

4
Refer to gynaecology if risk is elevated

A raised risk score, a complex-looking mass, or a postmenopausal woman with a mass typically leads to referral to a gynaecologist or gynaecological oncologist for further assessment, sometimes including an MRI or CT.

5
Treat or monitor an identified benign cause

If endometriosis, a simple functional cyst, fibroids, or PID explain the result, management focuses on that condition - for example, a repeat ultrasound in six to twelve weeks for a simple cyst, or antibiotics for PID.

6
Trend the marker over time

One number in isolation is rarely the full picture. Your GP will usually want to see whether CA-125 is stable, falling, or genuinely climbing over several tests before drawing conclusions.

7
Safety-net advice

You will usually be advised to return promptly if new symptoms develop - persistent bloating, pelvic pain, unexplained weight loss, or postmenopausal bleeding - regardless of what the last CA-125 result showed.

How Doctors Interpret a Raised CA-125

Risk of Malignancy Index (RMI)

When a pelvic mass has already been found on ultrasound, many Australian gynaecologists use the RMI, which multiplies an ultrasound feature score, a menopausal status score, and your CA-125 level together into a single number. A higher RMI indicates a greater chance the mass needs specialist surgical management rather than routine monitoring.

ROMA and HE4

The Risk of Ovarian Malignancy Algorithm (ROMA) combines CA-125 with a second blood marker, HE4 (human epididymis protein 4), and your menopausal status. HE4 is less affected by benign gynaecological conditions such as endometriosis, so combining the two markers can improve accuracy over CA-125 used alone.

Premenopausal versus postmenopausal context

The same CA-125 number is interpreted differently depending on menopausal status. Premenopausal women have far more common benign causes of a raised result (periods, ovulation, fibroids, endometriosis, cysts), so a mild elevation is usually reassuring. After menopause, most of those explanations become less likely, so a raised CA-125 with a pelvic mass is taken more seriously and investigated more promptly.

Why the trend matters more than one number

A single mildly raised CA-125 tells your doctor very little on its own. A value that is repeated and found to be stable or falling is reassuring, while one that keeps climbing over successive tests, independent of your menstrual cycle, is far more informative and worth investigating further.

Monitoring known ovarian cancer

For women already diagnosed with epithelial ovarian cancer, regular CA-125 testing is one of the standard tools used alongside imaging and clinical review to track how well treatment is working, and to help pick up recurrence early during follow-up. This use of CA-125 — tracking a known cancer over time — is quite different from a single unexpected raised result in a well woman, which is far more often benign.

High CA-125 — Frequently Asked Questions

What does it mean if my CA-125 is high?

A high CA-125 means the level of a protein called cancer antigen 125 in your blood is above the usual laboratory cutoff, typically around 35 U/mL in Australia. CA-125 is released whenever tissue lining the pelvis, uterus or abdominal cavity is irritated, so it rises with many common benign conditions - endometriosis, fibroids, ovarian cysts, a period, pregnancy, or recent surgery - and is not on its own a sign of cancer.

What is the normal range for CA-125 in Australia?

Most Australian pathology labs report a normal CA-125 as below 35 U/mL (some report below 30 or 46 U/mL, depending on the assay used), so always check the reference range printed on your own report. Mild elevations between 35 and 100 U/mL are common and frequently benign, especially in premenopausal women.

Can CA-125 be high without cancer being present?

Yes, very often. Endometriosis, uterine fibroids, menstruation, pregnancy, benign ovarian cysts, pelvic inflammatory disease, ascites from liver disease, and recent abdominal or pelvic surgery can all raise CA-125, sometimes substantially. In premenopausal women, a mildly raised CA-125 is far more likely to reflect one of these benign causes than cancer.

Is CA-125 used to screen for ovarian cancer?

No. CA-125 is not recommended as a screening test for ovarian cancer in women without symptoms, because large trials found it does not reduce ovarian cancer deaths when used alone in the general population and produces too many false positives. In Australia it is used mainly to monitor women already diagnosed with ovarian cancer and to help assess risk when a pelvic mass has already been found on ultrasound.

What are the RMI and ROMA scores?

The Risk of Malignancy Index (RMI) and the Risk of Ovarian Malignancy Algorithm (ROMA) are tools your gynaecologist may use when a pelvic mass has been found. RMI combines your CA-125 level, your menopausal status, and ultrasound features of the mass into a single risk score. ROMA combines CA-125 with a second marker called HE4 and your menopausal status. Both are more accurate than CA-125 alone at separating benign from concerning masses.

Can my period or ovulation affect my CA-125 result?

Yes. CA-125 can rise mildly around ovulation and during menstruation because the lining of the uterus and pelvis is naturally shedding and irritated. If your test happened to fall around this time, your GP will often simply repeat it at a different point in your cycle before pursuing further investigation.

When does a high CA-125 need urgent attention?

A high CA-125 needs prompt gynaecological assessment when it occurs in a postmenopausal woman together with a pelvic mass on ultrasound, when it keeps rising on repeat testing rather than settling, when there is new abdominal fluid (ascites), or when there is a strong family history of ovarian, breast or bowel cancer. Persistent bloating, pelvic pain, early fullness or urinary urgency occurring most days for more than three weeks should also be mentioned to your GP.


Got Your Blood Test Results?

Upload your results and SmarterBlood's AI will explain every marker — including tumour markers like CA-125 — in plain English, with Australian reference ranges and what each value really means for you.

This page provides general educational information about a raised CA-125 result. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your GP about abnormal blood test results — they have access to your full medical history and can interpret your results in context. SmarterBlood does not provide medical care.